- Home
- DYN vs STR Comparison
DYN vs STR Comparison
Compare DYN & STR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- STR
- Stock Information
- Founded
- DYN 1984
- STR 2016
- Country
- DYN United States
- STR United States
- Employees
- DYN N/A
- STR N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- STR Oil & Gas Production
- Sector
- DYN Health Care
- STR Energy
- Exchange
- DYN Nasdaq
- STR Nasdaq
- Market Cap
- DYN 1.2B
- STR 1.4B
- IPO Year
- DYN 2020
- STR N/A
- Fundamental
- Price
- DYN $9.38
- STR $18.30
- Analyst Decision
- DYN Strong Buy
- STR Buy
- Analyst Count
- DYN 15
- STR 6
- Target Price
- DYN $43.07
- STR $26.80
- AVG Volume (30 Days)
- DYN 3.3M
- STR 1.2M
- Earning Date
- DYN 08-11-2025
- STR 08-04-2025
- Dividend Yield
- DYN N/A
- STR 7.65%
- EPS Growth
- DYN N/A
- STR N/A
- EPS
- DYN N/A
- STR 0.52
- Revenue
- DYN N/A
- STR $636,538,000.00
- Revenue This Year
- DYN N/A
- STR N/A
- Revenue Next Year
- DYN N/A
- STR N/A
- P/E Ratio
- DYN N/A
- STR $35.15
- Revenue Growth
- DYN N/A
- STR 7.18
- 52 Week Low
- DYN $6.36
- STR $14.58
- 52 Week High
- DYN $47.45
- STR $25.52
- Technical
- Relative Strength Index (RSI)
- DYN 45.89
- STR 48.92
- Support Level
- DYN $8.95
- STR $17.56
- Resistance Level
- DYN $9.83
- STR $18.84
- Average True Range (ATR)
- DYN 0.55
- STR 0.54
- MACD
- DYN 0.17
- STR 0.01
- Stochastic Oscillator
- DYN 74.58
- STR 62.37
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.